The Venous Center

Filter Your Results

 

News

 

Nonfenestrated Options for Treating Compromised AAA Necks

Cornelis G. Vos, MD, PhD; Richte C.L. Schuurmann, MSc; and Jean-Paul P.M. de Vries, MD, PhD

March 2018—How to overcome juxtarenal AAAs.

Key Developments in Superficial Venous Disease Management

Raghu Kolluri, MD, RVT, RPVI; and Brian Fowler, BS, RVT

March 2018—A rundown of five significant advancements seen in the past year for the treatment and management of superficial venous disease.

Pelvic Congestion Syndrome: Underdiagnosed, Misdiagnosed, and Undertreated…or a Misnomer?

Paul J. Rochon, MD; and E. Brooke Spencer, MD, FSIR

January 2018—A discussion of clinical findings related to pelvic venous disease, emphasizing the need for greater suspicion of disease, as well as minimally invasive percutaneous treatment techniques.

Diagnosis and Treatment of Uterine and Pelvic Arteriovenous Malformations

Divya Sridhar, MD; and Robert L. Vogelzang, MD

January 2018—A review of etiology, clinical presentation and imaging findings, and treatment options for these two distinct entities.

An Interview With Stephen A. Black, MD, FRCS(Ed), FEBVS

November 2017—Mr. Black discusses when stent placement is ideal in patients with venous disease, the need for more accurate tools to measure inflow, and what’s next after ATTRACT.

OPTALYSE PE Demonstrated Significant Improvement in Right Ventricular Size With Shorter Infusion Times and Lower Doses of tPA, Making Ultrasound-Accelerated Thrombolysis Even Safer

Victor F. Tapson, MD

November 2017— The hypothesis of the OPTALYSE PE trial is that less-intensive thrombolytic therapy -- shorter infusions and lower doses of thrombolytics -- is safer and more advantageous…

Implementation of the OPTALYSE Study for Submassive Pulmonary Embolism: Patient Selection Criteria and Protocols

Noah J. Jones, MD, FACC, FSCAI

November 2017— Our hospital was one of the highest-enrolling sites in the OPTALYSE PE trial, which demonstrated that patients with submassive pulmonary embolism (PE) who received Acousti…

OPTALYSE PE: EKOS® Offers New Options for Treating Submassive PE Patients

Andrew S.P. Sharp, MBChB, MD, FRCP

November 2017— Each year, approximately 48,000 people suffer from a pulmonary embolism (PE) in the United Kingdom. About 40% of these patients have submassive PE, a condition that presen…

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.